Provided by Tiger Trade Technology Pte. Ltd.

ResMed

236.59
+4.141.78%
Pre-market: 235.00-1.5900-0.67%04:49 EDT
Volume:1.76M
Turnover:416.35M
Market Cap:34.13B
PE:22.68
High:238.37
Open:232.22
Low:231.89
Close:232.45
52wk High:286.91
52wk Low:180.27
Shares:144.25M
Float Shares:143.49M
Volume Ratio:1.33
T/O Rate:1.23%
Dividend:2.40
Dividend Rate:1.01%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:5.18
PE(LYR):22.68

Loading ...

U.S. Stocks on the MOVE-Atlassian, Macerich, DoubleVerify

Reuters
·
Aug 08

ResMed Shares Tumble as Weak 2027 Sales Forecast Eclipses Quarterly Profit Beat

Reuters
·
Aug 07

ResMed Price Target Cut to $215.00/Share from $225.00 by Wells Fargo

Dow Jones
·
Aug 07

ResMed Down Nearly 8%, on Pace for Largest Percent Decrease Since January 2025

Dow Jones
·
Aug 07

Movement Alert|ResMed Falls 7.69% in Regular Trading, Earnings Beat Estimates but Revenue Growth Slowdown Triggers Multiple Downgrades

Market Focus
·
Aug 07

RBC Capital Adjusts PT on ResMed to $244 From $234, Maintains Sector Perform Rating

MT Newswires Live
·
Aug 07

ResMed price target raised to $244 from $234 at RBC Capital

TIPRANKS
·
Aug 07

ResMed price target lowered to $213 from $217 at Baird

TIPRANKS
·
Aug 07

ResMed price target lowered to $215 from $225 at Wells Fargo

TIPRANKS
·
Aug 07

Resmed Shares Down 8.7% Premarket After Q4 Results

THOMSON REUTERS
·
Aug 07

Stock Track | ResMed Plunges 8.78% in 24-Hour Trading as Revenue Growth Deceleration Overshadows Q4 Earnings Beat

Stock Track
·
Aug 07

Movement Alert|ResMed Falls 8.41% in Pre-Market Trading, Earnings Beat Expectations but Revenue Growth Deceleration Sparks Concern

Market Focus
·
Aug 07

Resmed Inc. : RBC Raises Target Price to $244 from $234

THOMSON REUTERS
·
Aug 07

Resmed Inc. : Piper Sandler Cuts Target Price to $225 from $233

THOMSON REUTERS
·
Aug 07

Stock Track | ResMed Plunges 6.07% in 24-Hour Trading as Revenue Growth Deceleration Overshadows Q4 Earnings Beat

Stock Track
·
Aug 07

Movement Alert|ResMed Declines 6.15% Overnight, Earnings Beat but Revenue Growth Slowdown Sparks Concerns

Market Focus
·
Aug 07

Deferral of Conversions Between Australian and US Registers-RMD.N

Reuters
·
Aug 07

144 Report of Proposed Sale of Securities-RMD.N

Reuters
·
Aug 07

Resmed Q4 FY2026 Earnings: Revenue Rises as Safety Costs Weigh on GAAP Margins

TradingKey
·
Aug 07

ResMed Fiscal Q4 Non-GAAP Earnings, Revenue Up

MT Newswires Live
·
Aug 07